FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Defined. Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1459292019 Transdermal patch (product) en Fully specified name Inactive Initial character case insensitive SNOMED CT core
1479376011 Transdermal patch en Synonym Inactive Case insensitive SNOMED CT core
2621574015 Patch en Synonym Inactive Case insensitive SNOMED CT core
2660372013 Transdermal patch (qualifier value) en Fully specified name Inactive Case insensitive SNOMED CT core
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Case insensitive SNOMED CT core
3634739013 Prolonged-release transdermal patch en Synonym Active Case insensitive SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Some
Prolonged-release transdermal patch Is a Patch false Inferred relationship Some
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Some
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Some
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Some
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Some
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Some
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Estradiol 2.08 microgram/hour and norethisterone acetate 10.4 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 1.04 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 1.56 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 2.5 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 2.08 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 3.13 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 4.17 microgram/hour prolonged-release transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Selegiline 250 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 2.08 microgram/hour and norethisterone acetate 5.83 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 583 nanogram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Selegiline 500 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Oxybutynin 162 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Selegiline 375 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Nicotine 917 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Nicotine 458 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Rivastigmine 192 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Rivastigmine 396 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Rotigotine 125 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Rotigotine 41.667 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Buprenorphine 5 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Nicotine 1.563 mg/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Buprenorphine 15 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Capsaicin 179mg/hour transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Buprenorphine 20 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Buprenorphine 10 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Buprenorphine 5microgram/hour transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Nicotine 11mg/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Nicotine 22mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Glyceryl trinitrate 200 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Glyceryl trinitrate 400 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Glyceryl trinitrate 600 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Oestradiol 0.025mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Oestradiol 0.0375mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Oestradiol 0.05mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Oestradiol 0.075mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Oestradiol 0.1mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Scopolamine 0.5mg/24 hr patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Glyceryl trinitrate 300 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Oestradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Oestradiol 0.05mg/norethindrone acetate 0.25mg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Oestradiol 14mcg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Ethinyl oestradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Fentanyl 12 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Selegiline 6mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Selegiline 9mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Selegiline 12mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Rivastigmine 4.6mg/24 hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Rivastigmine 9.5mg/24 hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Oestradiol 0.06mg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Some
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 3.125 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 1.042 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 1.563 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 1.667 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Rotigotine 83.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 2.083 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 2.083 microgram/hour and norethisterone acetate 7.083 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 3.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Estradiol 4.167 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Hyoscine 13.889 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Fentanyl 25 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Testosterone 104.167 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Buprenorphine 35 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Fentanyl 50 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Buprenorphine 52.5 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Buprenorphine 70 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Fentanyl 75 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Fentanyl 100 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Granisetron 129.167 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Glyceryl trinitrate 208.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Testosterone 208.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Testosterone 250 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Nicotine 291.667 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Nicotine 312.5 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Glyceryl trinitrate 416.667 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Nicotine 583.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Glyceryl trinitrate 625 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Nicotine 625 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Rotigotine 250 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Nicotine 875 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some
Nicotine 937.5 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Some

Reference Sets

Qualifier value foundation reference set

Medication form reference set

Back to Start